Skip to content

Weight loss effect of medical nutrition fortification intervention combined with high-protein prepackaged food on obese patients

Weight loss effect of medical nutrition fortification intervention combined with high-protein prepackaged food on obese patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050960
Enrollment
Unknown
Registered
2021-09-08
Start date
2021-09-20
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Experimental group:Meal replacement + nutritionist enhanced dietary guidance

Sponsors

The First Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 60 years, no gender limit; 2. BMI>=28kg/m^2; 3. Stable weight, 3-month weight loss <=2.5kg; 4. Patients agree to voluntarily participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Liver function Child-Pugh score >= 7 points, that is, patients with moderate to severe liver function abnormalities; 2. Patients with chronic kidney disease; 3. History of malignant tumor; 4. History of severe cardiovascular or cerebrovascular disease (angina pectoris, myocardial infarction or stroke) within the past 6 months; 5. Diagnosed with gastrointestinal tumors, inflammatory bowel disease, irritable bowel syndrome and other serious gastrointestinal diseases or a history of gastrointestinal surgery within the past 12 months; 6. Pregnant and lactating patients, or patients planning to conceive within six months; 7. Participate in an intensive exercise training program (more than 210 minutes of moderate to high intensity training per week) or plan to start a new exercise program during the study period; 8. Taking prescription drugs for weight loss in the past 6 months; 9. In addition to the above criteria, the trial was determined in the judgment of the investigator to be unsafe or unsuitable for potential participants.

Design outcomes

Primary

MeasureTime frame
Body mass index;

Secondary

MeasureTime frame
Body composition;Inflammatory markers;Safety index;Eating habits and living habits;Adverse reactions;Shedding rate;Compliance;European Five-Dimensional Health Scale;

Countries

China

Contacts

Public ContactSui Yi
suiyi@mail.sysu.edu.cn+86 20 87338179

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026